Sanofi says Gaucher pill studies meet goals

[riky]

Sanofi says Gaucher pill studies meet goals

<p><a href="http://news.yahoo.com/sanofi-says-gaucher-pill-meets-goals-stage-tests-164254898--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/Sqt2gEw2DaMkPW3IiGumMg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-02-15T164254Z_1_CBRE91E1AFP00_RTROPTP_2_SANOFI-RESULTS.JPG" width="130" height="86" alt="Chris Viehbacher, CEO of Sanofi, attends the company's 2012 annual results presentation in Paris" align="left" title="Chris Viehbacher, CEO of Sanofi, attends the company's 2012 annual results presentation in Paris" border="0" /></a>PARIS (Reuters) - Sanofi said its experimental pill for Gaucher disease met its main targets in two late-stage studies, which the French drugmaker will use to bolster its case for regulatory approval. Eliglustat tartrate could become the first oral treatment for Gaucher disease - a rare genetic disorder affecting some 10,000 patients - and shake up the market for therapies that currently have to be injected bi-weekly. Eliglustat could generate annual sales of $360 million by 2017, according to ThomsonReuters Pharma forecasts. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login